한빛사논문
Jungho Ahna,b,1, Da-Hyun Kimc,1, Dong-Jun Kood,e,1, Jungeun Lima, Tae-Eun Parkf, Jungseub Leea, Jihoon Koa, Seongchan Kimg, Minjae Kimg, Kyung-Sun Kangc, Dal-Hee Ming, Sung-Yon Kimd,e,g, YongTae Kimb,h,i,j, Noo Li Jeona,k,l
aDepartment of Mechanical and Aerospace Engineering, Seoul National University, Seoul 08826, Republic of Korea
bGeorge W. Woodruff School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA
cAdult Stem Cell Research Center and Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 08826, Republic of Korea
dInstitute of Molecular Biology and Genetics, Seoul National University, Seoul 08826, South Korea
eProgram in Neuroscience, Seoul National University, Seoul 08826, South Korea
fUlsan National Institute of Science and Technology, Ulsan 44914, Republic of Korea
gDepartment of Chemistry, Seoul National University, Seoul 08826, Republic of Korea
hParker H. Petit Institute for Bioengineering and Bioscience, Georgia Institute of Technology, Atlanta, GA 30332, USA
iInstitute for Electronics and Nanotechnology, Georgia Institute of Technology, Atlanta, GA 30332, USA
jWallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, GA 30332, USA
kDivision of WCU (World Class University) Multiscale Mechanical Design, Seoul National University, Seoul 08826, Republic of Korea
lSeoul National University Institute of Advanced Machines and Design, Seoul 08826, Republic of Korea
1These authors contributed equally to this work.
Corresponding authors.: Sung-Yon Kim, YongTae Kim, Noo Li Jeon
Abstract
Tumor angiogenesis is regarded as a promising target for limiting cancer progression because tumor-associated vasculature supplies blood and provides a path for metastasis. Thus, in vitro recapitulation of vascularized tumors is critical to understand the pathology of cancer and identify the mechanisms by which tumor cells proliferate, metastasize, and respond to drugs. In this study, we microengineered a vascularized tumor spheroid (VTS) model to reproduce the pathological features of solid tumors. We first generated tumor-EC hybrid spheroids with self-assembled intratumoral vessels, which enhanced the uniformity of the spheroids and peritumoral angiogenic capacity compared to spheroids composed only with cancer cells. Notably, the hybrid spheroids also exhibited expression profiles associated with aggressive behavior. The blood vessels sprouting around the hybrid spheroids on the VTS chip displayed the distinctive characteristics of leaky tumor vessels. With the VTS chip showing a progressive tumor phenotype, we validated the suppressive effects of axitinib on tumor growth and angiogenesis, which depended on exposure dose and time, highlighting the significance of tumor vascularization to predict the efficacy of anticancer drugs. Ultimately, we effectively induced both lymphangiogenesis and angiogenesis around the tumor spheroid by promoting interstitial flow. Thus, our VTS model is a valuable platform with which to investigate the interactions between tumor microenvironments and explore therapeutic strategies in cancer.
논문정보
관련 링크
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기